Hanmi Reintroduces Liver Drug After Raising Bioavailability
After leveraging its microemulsion technology to increase the absorption rate and so address a shortcoming of the original formulation, Hanmi Pharmaceutical has reintroduced its...
Three Viruses That Pharma Sector Needs To Gear Up Against
More than half of the known infectious diseases are getting worse due to climate change. Monkeypox is expanding, and recently, news of an outbreak...
New Zealand Advances Alzheimers Drug Development Process
Researchers from the University of Otago in New Zealand have taken advantage of a brain protein that has a strong chance of delaying or...
Pharma Criticises Drug Pricing Bill As Patient Groups Cheer
The pharmaceutical lobbying group's aura of invincibility has faded. The U.S. Senate recently passed a new bill, leaving the pharmaceutical sector licking its wounds...
Pharmacopoeias To Promote Vaccine Development And Supply
The mRNAVAC Working Party was established by the European Pharmacopoeia Commission to start developing standards of quality to support the developing area of messenger...
Why Children Are Better Protected Against COVID-19 & More
There were a lot of mysteries surrounding COVID-19, some of which have been answered, but many more have not. Since the start of the...
AstraZeneca’s Enhertu wins keenly-anticipated U.S. breast cancer nod
AstraZeneca (AZN.L) and Daiichi Sankyo (4568.T) on Friday secured U.S. approval that broadens the use of their therapy Enhertu, for patients with breast cancer, and paves the way...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...